News|Articles|June 1, 2026

Global leader in engagement with healthcare stakeholders

Reverba Global (formerly Health Perspectives Group) is a scientific engagement company that empowers biopharmaceutical companies to connect with patients and healthcare providers to improve health outcomes. Reverba Global’s Patient Experience Engine combines more than 20 years of patient engagement with proprietary scalable technology, compliance expertise and deep scientific knowledge to deliver real-time insights, from discovery through commercialization.

Explore Content Engagement Hub Resources from Reverba Global. Click Below.

Related to this article

Pharmaceutical executive daily
A new ICER and West Health report finds median drug launch prices climbed to $257,000, the FDA approves GSK’s Hibsago as the first functional-cure therapy for chronic hepatitis B, and CSL names Deborah Waterhouse as CEO and managing director.